Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
AT THE END OF EACH YEAR, IT IS GENERALLY EASY TO PICK OUT the stories of greatest significance for the lab industry during the previous 12 months. But what is often overlooked are the non-stories. These are the events that did not happen in the year, despite earlier occurrences and the momentum pushing certain trends […]
Lab Industryâs Non-Stories for 2015 Read More »
AT THE END OF EVERY YEAR, ITâS ALWAYS SMART BUSINESS FOR EVERY LAB to peer into the future specifically to identify the best clinical and financial opportunities. With the New Year just a few weeks away, this issue of THE DARK REPORT is designed to help you and your management team prepare for whatâs coming
Opportunities Ahead for Labs That Prepare Read More »
FOR MORE THAN TWO YEARS, Theranos, the lab testing company that says it intends to disrupt the clinical lab industry, has been the subject of cover sto- ries in many prominent consumer and business publications. Its masterful public relations campaign seems to have touched almost every hospital and health system CEO in this country. How
Hospital CEOs Have Nothing to Fear from Theranos Read More »
WE ARE JUST ABOUT EIGHT WEEKS FROM THE ADVENT OF 2016. Given the rapid transformation of healthcare that continues to unfold, it is timely to assess how clinical labs and pathology groups are likely to fare during the coming year. On the plus side, the ongoing evolution toward integration of clinical care will benefit hospital-based
Will 2016 Bring Opportunity or Tribulations for Labs? Read More »
BY NOW, MOST OF YOU HAVE LEARNED  that, just 12 days ago, CMS issued the proposed rule that details how it will handle the private market price reporting mandate of the Protecting Access to Medicare Act of 2014 (PAMA). Almost immediately, critics spoke out about the obvious inequities that will result from implementing the proposed rule. Let
Did Some Lab Execs âGet What They Wished For?â Read More »
IT’S THE $1 BILLION LAB FRAUD that no one realized had grown that big! In this special issue of THE DARK REPORT, you’ll read about how the next chapter of the federal whistleblower lawsuit against three specialty cardiology labs and certain individuals has pulled the curtain open on what we think is the biggest case of laboratory fraud and abuse in the past 30 years.
Why Medicare Fraud Hurts Entire Lab Industry Read More »
ONE OF THE NATIONâS LONGEST-RUNNING LAB OUTREACH JOINT VENTURES involving a public lab company and a major hospital came to a quiet end on June 30. Thatâs the day when United/Dynacare Laboratories, LLC, ceased to exist.
LabCorp Loses A Hospital Lab Joint Venture Read More »
THERE HAS BEEN EXPLOSIVE GROWTH IN THE NUMBER OF PATIENTS enrolled in high- deductible health plans. Currently, more than 20 million people have HDHPs. This is one reason why many labs are experiencing high levels of patient bad debt never before seen by the lab industry during the past three decades.
Collecting Big Patient Deductibles Read More »
FURTHER CONSOLIDATION AMONG THE NATIONâS LARGEST HEALTH INSURANCE COMPANIES is expected following the news on July 3, that Aetna, Inc., and Humana, Inc., had entered a sales agreement calling for Aetna to pay $37 billion to acquire Humana.
Will Humanaâs Sale to Aetna Hurt Smaller Labs? Read More »
FOR MORE THAN 20 YEARS, THE CLINICAL LAB INDUSTRY been marked by a fundamental schism. On one side of the schism are the public lab companies that have aggressively used deeply-discounted loss-leader pricing practices when negotiating managed care contracts to capture market share.
Deep-Discount Lab Prices to Haunt All California Labs Read More »
The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com
© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group